CD48 on hematopoietic progenitors regulates stem cells and suppresses tumor formation

被引:31
作者
Boles, Nathan C. [1 ,2 ]
Lin, Kuanyin K. [2 ]
Lukov, Georgi L. [3 ]
Bowman, Teresa V. [4 ]
Baldridge, Megan T. [3 ]
Goodell, Margaret A. [1 ,2 ,3 ,5 ]
机构
[1] Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA
[2] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[4] Childrens Hosp Boston, Stem Cell Program, Boston, MA USA
[5] Baylor Coll Med, Dept Genet, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
LINKED LYMPHOPROLIFERATIVE DISEASE; NATURAL-KILLER-CELLS; INTERFERON-GAMMA PRODUCTION; P21-ACTIVATED KINASE PAK; SELF-RENEWAL; RECEPTOR; 2B4; IFN-GAMMA; CUTTING EDGE; IN-VIVO; ACTIVATION;
D O I
10.1182/blood-2010-12-322339
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The proliferation and differentiation of adult stem cells is balanced to ensure adequate generation of differentiated cells, stem cell homeostasis, and guard against malignant transformation. CD48 is broadly expressed on hematopoietic cells but excluded from quiescent long-term murine HSCs. Through its interactions with CD244 on progenitor cells, it influences HSC function by altering the BM cytokine milieu, particularly IFN gamma. In CD48-null mice, the resultant misregulation of cytokine signaling produces a more quiescent HSC, a disproportionate number of short-term progenitors, and hyperactivation of Pak1, leading to hematologic malignancies similar to those found in patients with X-linked lymphoproliferative disease. CD48 plays a vital role as an environmental sensor for regulating HSC and progenitor cell numbers and inhibiting tumor development. (Blood. 2011;118(1):80-87)
引用
收藏
页码:80 / 87
页数:8
相关论文
共 51 条
[1]   2B4/CD48-mediated regulation of lymphocyte activation and function [J].
Assarsson, E ;
Kambayashi, T ;
Persson, CM ;
Chambers, BJ ;
Ljunggren, HG .
JOURNAL OF IMMUNOLOGY, 2005, 175 (04) :2045-2049
[2]   Quiescent haematopoietic stem cells are activated by IFN-γ in response to chronic infection [J].
Baldridge, Megan T. ;
King, Katherine Y. ;
Boles, Nathan C. ;
Weksberg, David C. ;
Goodell, Margaret A. .
NATURE, 2010, 465 (7299) :793-U9
[3]   X-linked lymphoproliferative disease (XLP): a model of impaired anti-viral, anti-tumor and humoral immune responses [J].
Bassiri, Hamid ;
Yeo, W. C. Janice ;
Rothman, Jennifer ;
Koretzky, Gary A. ;
Nichols, Kim E. .
IMMUNOLOGIC RESEARCH, 2008, 42 (1-3) :145-159
[4]   Cutting edge: Defective NK cell activation in X-linked lymphoproliferative disease [J].
Benoit, L ;
Wang, XX ;
Pabst, HF ;
Dutz, J ;
Tan, R .
JOURNAL OF IMMUNOLOGY, 2000, 165 (07) :3549-3553
[5]   Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP) [J].
Brandau, O ;
Schuster, V ;
Weiss, M ;
Hellebrand, H ;
Fink, FM ;
Kreczy, A ;
Friedrich, W ;
Strahm, B ;
Niemeyer, C ;
Belohradsky, BH ;
Meindl, A .
HUMAN MOLECULAR GENETICS, 1999, 8 (13) :2407-2413
[6]   Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-γ but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro [J].
Carter, Sally L. ;
Mueller, Marcus ;
Manders, Peter M. ;
Campbell, Iain L. .
GLIA, 2007, 55 (16) :1728-1739
[7]  
CAUX C, 1992, BLOOD, V79, P2628
[8]   Mouse Hematopoietic Stem Cell Identification and Analysis [J].
Challen, Grant A. ;
Boles, Nathan ;
Lin, Karen Kuan-Yin ;
Goodell, Margaret A. .
CYTOMETRY PART A, 2009, 75A (01) :14-24
[9]  
Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003
[10]   Interleukin-18 is a novel mitogen of osteogenic and chondrogenic cells [J].
Cornish, J ;
Gillespie, MT ;
Callon, KE ;
Horwood, NJ ;
Moseley, JM ;
Reid, IR .
ENDOCRINOLOGY, 2003, 144 (04) :1194-1201